SCHEMBL31728787

SCHEMBL31728787

Nc1ncnc2c(-c3cccc(Cl)c3)c(C(F)(F)F)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 7/20 0.51
▸ LIMK1 P53667 1/20 0.49
▸ CLK1 P49759 2/20 0.45
▸ KDR P35968 2/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ ADK P55263 1/20 0.40
▸ IKBKE Q14164 1/20 0.39
▸ DHFR P00374 2/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ ABL2 P42684 1/20 0.37
▸ JAK2 O60674 1/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728354 0.81 MAP4K4 (0.54) MAP4K4LIMK1CLK1KDRADK
SCHEMBL31727760 0.77 MAP4K4 (0.48) MAP4K4LIMK1CLK1KDRADK
SCHEMBL31727762 0.75 MAP4K4 (0.48) MAP4K4LIMK1CLK1KDRADK
SCHEMBL31727978 0.73 DHFR (0.51) MAP4K4LIMK1CLK1KDRDHFR
SCHEMBL31728478 0.73 MAP4K4 (0.51) MAP4K4LIMK1CLK1KDRADK
SCHEMBL30762108 0.72 PDE5A (0.41) MAP4K4LIMK1CLK1KDRABL1
SCHEMBL29829936 0.72 PARP1 (0.49) MAP4K4LIMK1CLK1RPS6KB1
SCHEMBL31728362 0.71 MAP4K4 (0.45) MAP4K4LIMK1CLK1KDRADK
SCHEMBL31727973 0.71 MAP4K4 (0.45) MAP4K4LIMK1CLK1KDRDHFR
SCHEMBL31728147 0.70 MAP4K4 (0.47) MAP4K4LIMK1CLK1KDRADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback